1. Home
  2. GITS vs SNOA Comparison

GITS vs SNOA Comparison

Compare GITS & SNOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GITS

Global Interactive Technologies Inc.

HOLD

Current Price

$2.45

Market Cap

7.6M

Sector

N/A

ML Signal

HOLD

Logo Sonoma Pharmaceuticals Inc.

SNOA

Sonoma Pharmaceuticals Inc.

N/A

Current Price

$2.80

Market Cap

6.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GITS
SNOA
Founded
2018
1999
Country
South Korea
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.6M
6.1M
IPO Year
N/A
2006

Fundamental Metrics

Financial Performance
Metric
GITS
SNOA
Price
$2.45
$2.80
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
151.8K
11.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$14,288,000.00
Revenue This Year
N/A
$23.00
Revenue Next Year
N/A
$24.59
P/E Ratio
N/A
N/A
Revenue Growth
N/A
12.19
52 Week Low
$0.66
$1.77
52 Week High
$7.09
$6.92

Technical Indicators

Market Signals
Indicator
GITS
SNOA
Relative Strength Index (RSI) 50.26 33.84
Support Level $2.13 N/A
Resistance Level $3.28 $3.82
Average True Range (ATR) 0.51 0.11
MACD -0.05 0.01
Stochastic Oscillator 32.88 21.95

Price Performance

Historical Comparison
GITS
SNOA

About GITS Global Interactive Technologies Inc.

Global Interactive Technologies Inc, formerly Hanryu Holdings Inc is the creator of the engaging social media platform, FANTOO. Through FANTOO, it provides a multi-media platform for its users to interact with other like-minded users, share their appreciation of various types of entertainment and cultures, create their content, enjoy content, and engage in commerce.

About SNOA Sonoma Pharmaceuticals Inc.

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.

Share on Social Networks: